Thirdly, tauopathies have the smallest basal forebrain volumes, driven by both patients with FTDP-17 (i.e. MAPT mutations) and Pick's disease, whilst in the TDP-43 proteinopathies, lower volumes are driven by a decrease in those with type C pathology. This evidence concerns the gene MAPT and frontotemporal dementia.